segunda-feira, 24 de outubro de 2011

Valley surgeon heads up test of aneurysm treatment - Orlando Business Journal:

vidineevostegity.blogspot.com
Rodriguez, the director of peripheraol vascular services at the Arizona Heart has been named the nationak principal investigator for the Phase II which is required by the to enroll 160 The Arizona Heart Institute is one of 14 centersz involved in thestudy nationwide. “Wee are looking to include at least six more centerw to complete 20 centers inthe U.S.,” Rodriguezz said. The endoluminal graft is manufacturede bynear Glasgow, Scotland. Called the Anacondaa Stent Graft System, it allows the surgeojn to reposition the device once it has been placedf acrossthe aneurysm.
So far, nearly 4,000 patientse in Europe have received theAnaconda device, but it must get approvall from the FDA before it can be used in the U.S. Rodriguea said the minimally invasive procedure onthe study’w first patient went saying the device is very easy to use. “Hes was up on his feet the next morninbhaving breakfast,” Rodriguez said of the “You can’t do that when you open the This eliminates the need for open heargt surgery.” Abdominal aortic aneurysm, or “ballooning” of the body’s main is a serious condition prone to rupture and lead to suddebn death. Actor John Ritter died of an aorti rupturein 2003.
Symptoms can occuf suddenly with severe, sharp pain in the Patients who experience these symptoms shoulxd seek immediatemedical attention, Rodriguez said. Early detection can preventt sudden death. Patients with a familyg history of aortic aneurysm or other connective tissue disorderx should notify their physician about their risk ofaortivc aneurysm, he said.

Nenhum comentário:

Postar um comentário